A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan-Reference-Cited by-同舟云学术

A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan

Published:2023-06-12 Issue: Volume: Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Yamaguchi Satoshi¹,Yamazaki Miho¹,Kido Toshiki¹,Hounoki Hiroyuki¹,Muraishi Nozomu²,Tajiri Kazuto²,Tanaka Shinichi³,Tobe Kazuyuki¹,Shinoda Koichiro¹^ORCID

Affiliation:

1. First Department of Internal Medicine, University of Toyama , Toyama, Japan

2. Third Department of Internal Medicine, University of Toyama , Toyama, Japan

3. Department of Diagnostic Pathology, University of Toyama , Toyama, Japan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/kead285/50659447/kead285.pdf

Reference6 articles.

1. 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides;Jennette;Arthritis Rheum,2013

2. Avacopan for the treatment of ANCA-associated vasculitis;Jayne;N Engl J Med,2021

3. Vanishing bile duct syndrome in an adult patient: case report and review of the literature;Izzo;J Clin Med,2022

4. Strong pharmacokinetic drug-drug interactions with drugs approved by the US Food and Drug Administration in 2021: mechanisms and clinical implications;Yu;Clin Ther,2022

5. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone;Kathi;Clin J Gastroenterol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world study;Rheumatology;2024-07-13

2. Avacopan/methylprednisolone/prednisolone;Reactions Weekly;2024-04-27

3. Comment on: A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan;Rheumatology;2023-10-25

4. Severe prolonged liver abnormality with jaundice during treatment for granulomatosis with polyangiitis with rituximab and avacopan;Rheumatology;2023-09-22